Starling Oncology, Inc. Cash
Starling Oncology, Inc. (STLN) had Cash of $204.87 thousand as of 2021-09-30, per its 10-Q/A filed 2021-12-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-12-14
- 2021-09-30: Cash $204.87K.
- 2021-06-30: Cash $620.73K.
- 2021-03-31: Cash $573.33K.
- 2020-12-31: Cash $916.99K.
| Period end | Cash |
|---|---|
| 2021-09-30 | $204.87K 10-Q/A · filed 2021-12-14 |
| 2021-06-30 | $620.73K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $573.33K 10-Q · filed 2021-05-28 |
| 2020-12-31 | $916.99K 10-K/A · filed 2021-12-14 |
| 2020-09-30 | $998.57K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.51M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $25.00K 10-K/A · filed 2021-12-14 |